We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · October 16, 2021

Use of IVIG in Vaccine-Induced ITP



Additional Info

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
Blood 2021 Sep 16;138(11)992-996, G Uzun, K Althaus, A Singh, P Möller, U Ziemann, A Mengel, P Rosenberger, M Guthoff, GC Petzold, J Müller, M Büchsel, K Feil, H Henkes, N Heyne, M Maschke, C Limpach, S Nagel, UJ Sachs, F Fend, T Bakchoul

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading